FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology. Methods of using molecular imprinted polymers (MIP) for preparing pharmaceutical composition for treating, reducing or preventing various diseases, caused by disturbance of metabolism of amino acids or carbohydrates, are disclosed. Application involves introduction in gastrointestinal tract of patient effective amount of MIP composition. MIP composition is capable of binding an agent, accumulation of which causes symptoms of above disease wherein MIP are insoluble, and therefore, they can penetrate through gastrointestinal tract mucosa.
EFFECT: this invention allows to reduce incoming of toxic substances, agents causing said disease into blood flow.
13 cl
| Title | Year | Author | Number |
|---|---|---|---|
| PRODUCTION OF MOLECULAR-IMPRINTED POLYMERS AS RESULT OF CROSS-LINKING | 2012 |
|
RU2608743C2 |
| ANTIKINE ANTIBODIES BINDING TO SEVERAL CC-CHEMOKINES | 2010 |
|
RU2574786C2 |
| IMPROVED OBTAINING OF POLYMERS WITH MOLECULAR IMPRESSIONS | 2007 |
|
RU2437665C2 |
| METHODS OF TREATING CHRONIC PAIN | 2009 |
|
RU2522493C2 |
| ANTIBODY Fc VARIANTS | 2012 |
|
RU2607014C2 |
| METHOD FOR SELECTION AND OBTAINING OF HIGHLY SELECTIVE AND MULTISPECIFIC TARGETING GROUPS WITH SPECIFIED PROPERTIES, INCLUDING AT LEAST TWO DIFFERENT BINDING GROUPS, AND THEIR APPLICATIONS | 2013 |
|
RU2639287C2 |
| ANTAGONISTS AND METHOD OF USING SAID ANTAGONISTS | 2005 |
|
RU2401842C2 |
| MULTI-SPECIFIC OR BISPECIFIC MOLECULE (VERSIONS), METHOD FOR ELIMINATION OR DECREASING QUANTITY OF TARGET CELLS IN SUBJECT'S BODY, METHOD FOR TREATING PATHOGEN-INFECTED SUBJECT AND METHOD FOR SUBJECT'S VACCINATION | 1997 |
|
RU2201766C2 |
| GENETICALLY ENGINEERED POLYPEPTIDES AND USE THEREOF | 2017 |
|
RU2822498C2 |
| MULTIVALENT ANTIGEN-BINDING FV MOLECULE | 2011 |
|
RU2613368C2 |
